CD1d-associated expression of NF-κB and cardiac dysfunction in diabetic and obese mice

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 1, 2013, Pages 59-73

  Madonna, R ^a   Wu, H ^a   Shelat, H ^a   Geng, Yong Jian ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Diabetes mellitus; Diastolic dysfunction; Low grade chronic inflammation; Nuclear transcription factor CD1d; Obesity; Type 2

Indexed keywords

CD1D ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; PROTEIN P52; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; INNATE IMMUNITY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; ANIMAL CELL; BLOOD FLOW VELOCITY; DIASTOLIC DYSFUNCTION; KNOCKOUT MOUSE; NATURAL KILLER T CELL; OBESITY;

EID: 84881223631     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201302600106     Document Type: Article

References (37)

1. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 2002; 5:551-59. (Pubitemid 40684652)
2. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24:278-301. (Pubitemid 36724371)
3. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27:813-23. (Pubitemid 38280558)
4. Zimmer MI, Colmone A, Felio K, Xu H, Ma A, Wang CR. A cell-type specific cd1d expression program modulates invariant nkt cell development and function. J Immunol 2006; 176:1421-30. (Pubitemid 43134284)
5. Apostolou I, Cumano A, Gachelin G, Kourilsky P. Evidence for two subgroups of cd4-cd8- nkt cells with distinct tcr alpha beta repertoires and differential distribution in lymphoid tissues. J Immunol 2000; 165:2481-90. (Pubitemid 30660693)
6. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. Nkt cells: What's in a name? Nat Rev Immunol 2004; 4:231-37. (Pubitemid 38339089)
7. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, Van Kaer L. Cd1d1 mutant mice are deficient in natural t cells that promptly produce il-4. Immunity 1997; 6:469-77. (Pubitemid 27208202)
8. Bierhaus A, Schiekofer S, Schwaninger M, et el. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappab. Diabetes 2001; 50:2792-808.
9. Bonizzi G, Karin M. The two nf-kappab activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25:280-88. (Pubitemid 38610351)
10. Pahl HL. Activators and target genes of rel/nf-kappab transcription factors. Oncogene 1999; 18:6853-66.
11. Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, Chen Y, Hu Y, Fong A, Sun SC, Karin M. Activation by ikkalpha of a second, evolutionary conserved, nf-kappa b signaling pathway. Science 2001; 293:1495-99. (Pubitemid 32801552)
12. Chen H, Charlat O, Tartaglia LA, et al. Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84:491-95. (Pubitemid 26060722)
13. Coleman DL. Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978; 14:141-48. (Pubitemid 8286141)
14. Madonna R, Di Napoli P, Massaro M, Grilli A, Felaco M, De Caterina A, Tang D, De Caterina R, Geng YJ. Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts. J Biol Chem 2005; 280:13503-11. (Pubitemid 40517241)
15. Nielsen LB, Bartels ED, Bollano E. Overexpression of apolipoprotein b in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 2002; 277:27014-20. (Pubitemid 34951713)
16. Maisel AS, Krishnaswamy P, Nowak RM, et al, Breathing Not Properly Multinational Study I. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-67. (Pubitemid 34764819)
17. Park JH, Kim YG, Shaw M, Kanneganti TD, Fujimoto Y, Fukase K, Inohara N, Nunez G. Nod1/rick and tlr signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 2007; 179:514-21. (Pubitemid 46986568)
18. Miyazaki Y, Iwabuchi K, Iwata D, et al. Effect of high fat diet on nkt cell function and nkt cell-mediated regulation of th1 responses. Scand J Immunol 2008; 67:230-37. (Pubitemid 351197163)
19. Kronenberg M. Toward an understanding of nkt cell biology: Progress and paradoxes. Annu Rev Immunol 2005; 23:877-900. (Pubitemid 40563188)
20. Zhou D, Mariner J, Cantu C, 3rd, et al. Lysosomal glycosphingolipid recognition by nkt cells. Science 2004; 306:1786-89. (Pubitemid 39601398)
21. Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of nf-kappab in the heart: To be or not to nf-kappab. Circ Res 2011; 108:1122-32.
22. Haugen E, Chen J, Wikstrom J, Gronros J, Gan LM, Fu LX. Parallel gene expressions of il-6 and bnp during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats. Int J Cardiol 2007; 115:24-28. (Pubitemid 44855186)
23. Hayden MS, Ghosh S. Signaling to nf-kappab. Genes Dev 2004; 18:2195-224.
24. Perkins ND. Post-translational modifications regulating the activity and function of the nuclear factor kappa b pathway. Oncogene 2006; 25:6717-30. (Pubitemid 44657848)
25. Loverre A, Ditonno P, Crovace A, et al. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: Differential modulation by rapamycin. J Am Soc Nephrol 2004; 15:2675-86. (Pubitemid 41103374)
26. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci USA 2000; 97:1784-89. (Pubitemid 30118520)
27. Pierce GN, Kutryk MJ, Dhalla NS. Alterations in ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci USA 1983; 80:5412-16. (Pubitemid 13050231)
28. Backman L, Freyschuss U, Hallberg D, Melcher A. Cardiovascular function in extreme obesity. Acta Med Scand 1973; 193:437-46.
29. Glenn DJ, Wang F, Nishimoto M, Cruz MC, Uchida Y, Holleran WM, Zhang Y, Yeghiazarians Y, Gardner DG. A murine model of isolated cardiac steatosis leads to cardiomyopathy. Hypertension 2011; 57:216-22.
30. Laine GA, Allen SJ. Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991; 68:1713-21.
31. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham heart study. Circulation 1983; 67:968-77. (Pubitemid 13080473)
32. Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 1976; 60:645-53.
33. Soufer R, Wohlgelernter D, Vita NA, Amuchestegui M, Sostman HD, Berger HJ, Zaret BL. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985; 55:1032-36. (Pubitemid 15085358)
34. Mizelle HL, Edwards TC, Montani JP. Abnormal cardiovascular responses to exercise during the development of obesity in dogs. Am J Hypertens 1994; 7:374-78. (Pubitemid 24138026)
35. Carroll JF, Jones AE, Hester RL, Reinhart GA, Cockrell K, Mizelle HL. Reduced cardiac contractile responsiveness to isoproterenol in obese rabbits. Hypertension 1997; 30:1376-81. (Pubitemid 27528078)
36. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type ii diabetic rat model. Circulation 2000; 101:899-907. (Pubitemid 30117886)
37. Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 2002; 98:33-39. (Pubitemid 35375651)